Approvals/TGA/Irbesartan/Hydrochlorothiazide LAPL 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablet blister pack

Approved

STANDARD

Irbesartan/Hydrochlorothiazide LAPL 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablet blister pack

Lupin Australia Pty Limited🇦🇺 Therapeutic Goods Administration

Approval Id: 5f5c9b5ef3c85aa4
Product Name: Irbesartan/Hydrochlorothiazide LAPL 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablet blister pack
Artg Id: 190116
Artg Name: Irbesartan/Hydrochlorothiazide LAPL 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablet blister pack
Sponsor: Lupin Australia Pty Limited
Company Detail Path: /organization/lupin-australia-pty-limited
Artg Date: 2013-06-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

5f5c9b5ef3c85aa4

Type

Standard